OBJECTIVES: Our objective is to report prevalence of motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints, in multiple countries, and its association with dementia risk. METHODS: Pooled MCR prevalence analysis of individual data from 26,802 adults without dementia and disability aged 60 years and older from 22 cohorts from 17 countries. We also examined risk of incident cognitive impairment (Mini-Mental State Examination decline ≥4 points) and dementia associated with MCR in 4,812 individuals without dementia with baseline Mini-Mental State Examination scores ≥25 from 4 prospective cohort studies using Cox models adjusted for potential confounders. RESULTS: At baseline, 2,808 of the 26,802 participants met MCR criteria. Pooled MCR prevalence was 9.7% (95% confidence interval [CI] 8.2%-11.2%). MCR prevalence was higher with older age but there were no sex differences. MCR predicted risk of developing incident cognitive impairment in the pooled sample (adjusted hazard ratio [aHR] 2.0, 95% CI 1.7-2.4); aHRs were 1.5 to 2.7 in the individual cohorts. MCR also predicted dementia in the pooled sample (aHR 1.9, 95% CI 1.5-2.3). The results persisted even after excluding participants with possible cognitive impairment, accounting for early dementia, and diagnostic overlap with other predementia syndromes. CONCLUSION: MCR is common in older adults, and is a strong and early risk factor for cognitive decline. This clinical approach can be easily applied to identify high-risk seniors in a wide variety of settings.
OBJECTIVES: Our objective is to report prevalence of motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints, in multiple countries, and its association with dementia risk. METHODS: Pooled MCR prevalence analysis of individual data from 26,802 adults without dementia and disability aged 60 years and older from 22 cohorts from 17 countries. We also examined risk of incident cognitive impairment (Mini-Mental State Examination decline ≥4 points) and dementia associated with MCR in 4,812 individuals without dementia with baseline Mini-Mental State Examination scores ≥25 from 4 prospective cohort studies using Cox models adjusted for potential confounders. RESULTS: At baseline, 2,808 of the 26,802 participants met MCR criteria. Pooled MCR prevalence was 9.7% (95% confidence interval [CI] 8.2%-11.2%). MCR prevalence was higher with older age but there were no sex differences. MCR predicted risk of developing incident cognitive impairment in the pooled sample (adjusted hazard ratio [aHR] 2.0, 95% CI 1.7-2.4); aHRs were 1.5 to 2.7 in the individual cohorts. MCR also predicted dementia in the pooled sample (aHR 1.9, 95% CI 1.5-2.3). The results persisted even after excluding participants with possible cognitive impairment, accounting for early dementia, and diagnostic overlap with other predementia syndromes. CONCLUSION: MCR is common in older adults, and is a strong and early risk factor for cognitive decline. This clinical approach can be easily applied to identify high-risk seniors in a wide variety of settings.
Authors: David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson Journal: Curr Alzheimer Res Date: 2012-07 Impact factor: 3.498
Authors: Manuel Montero-Odasso; Susan W Muir; Maggie Hall; Timothy J Doherty; Marita Kloseck; Olivier Beauchet; Mark Speechley Journal: J Gerontol A Biol Sci Med Sci Date: 2011-02-28 Impact factor: 6.053
Authors: Joe Verghese; Mohan L Noone; Beena Johnson; Anne F Ambrose; Cuiling Wang; Herman Buschke; Vayyattu G Pradeep; Kizhakkaniyakath Abdul Salam; Kunnukatil S Shaji; Pavagada S Mathuranath Journal: J Am Geriatr Soc Date: 2012-10-05 Impact factor: 5.562
Authors: Ana Luisa Sosa; Emiliano Albanese; Blossom C M Stephan; Michael Dewey; Daisy Acosta; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Ivonne Z Jiménez-Velázquez; Juan J Llibre Rodriguez; Aquiles Salas; Joseph Williams; Isaac Acosta; Maribella González-Viruet; Milagros A Guerra Hernandez; Li Shuran; Martin J Prince; Robert Stewart Journal: PLoS Med Date: 2012-02-07 Impact factor: 11.069
Authors: Joe Verghese; Emmeline Ayers; Nir Barzilai; David A Bennett; Aron S Buchman; Roee Holtzer; Mindy J Katz; Richard B Lipton; Cuiling Wang Journal: Neurology Date: 2014-10-31 Impact factor: 9.910
Authors: Nan Wang; Gilles Allali; Chandrasekharan Kesavadas; Mohan L Noone; Vayyattu G Pradeep; Helena M Blumen; Joe Verghese Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Olivier Beauchet; Cédric Annweiler; Michele L Callisaya; Anne-Marie De Cock; Jorunn L Helbostad; Reto W Kressig; Velandai Srikanth; Jean-Paul Steinmetz; Helena M Blumen; Joe Verghese; Gilles Allali Journal: J Am Med Dir Assoc Date: 2016-02-04 Impact factor: 4.669
Authors: Klaus Jahn; Reto W Kressig; Stephanie A Bridenbaugh; Thomas Brandt; Roman Schniepp Journal: Dtsch Arztebl Int Date: 2015-06-05 Impact factor: 5.594